How imaging leaders are standardizing CT contrast use across an enterprise
With CT scan volumes soaring, IV contrast use becomes an ever-growing conversation clinically, operationally and financially. By the numbers, there were 93 million CT exams performed in U.S. facilities in 2023, with about half using contrast, according to data from IMV.
So, how do we manage contrast utilization better for patients, clinicians and healthcare facilities? Three clinical experts have some good advice to share in a Radiology Business open access webinar next week on Wed. Nov. 18th at 1 PM ET. During the live Q&A, attendees also have the opportunity to pose questions to the panel. Registrants who can’t attend live can sign up and watch later.
Here are some topics the experts will cover:
· Ways to keep protocols and image quality consistent across growing multi-site health systems
· Trade-offs between fixed and personalized protocols
· Weight dosing
· Limits of managing injector settings by hand
· Metrics that show whether protocols are being followed consistently across sites
The panel from Bayer Radiology includes: Joanne Hoener, RT (R) (CT) (MR), Bayer Clinical Specialist, Launch Excellence Team; Shonda Butler, Radiology Clinical Strategist, and Alex Rauluk, Product Marketing Lead.
Attendees also will get a preview of three upcoming software products that work with Bayer’s injectors: Smart Protocols for automated, patient-specific dosing; Injector Management for central protocol deployment across an injector fleet; and Workflow Solutions Insights for tracking adherence and contrast use.
The session is aimed at radiologists, imaging directors, CT administrators and technologists, as well as pharmacy and procurement staff who weigh in on contrast decisions. Sign up now for From Protocols to Practice: Advancing CT Contrast Stewardship Through Technology.
